What’s on your mind: Opinions


Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at

Product Description

Your Year in Review

In the October issue of PharmaVOICE, we asked how the events of this year — from new regulations to the economy — have shaped the life-sciences industry. ­PharmaVOICE wanted to know what events or industry trends have had the greatest impact on your strategies, executive positions, and business.

The Economy
Mark S. Perlotto
, Executive VP, General Manager, Adair-Greene Healthcare Communications

M&A activity
Nailesh A. Bhatt
, Managing Director, Proximare Inc.

Procurement Policies
Arthur A. Anderson
, Managing Principal, Morgan Anderson Consulting

Marketing Guidelines
Ash Nashed, M.D.
, President, Choice Media

The PhRMA Code
Martin E. Cearnal
, President and CEO, Thomson Physicians World

A Tough Year
Rich Levy
, CEO, Adair-Greene Inc.

Five Trends
Bob Preston
, CEO, MultiMedia HealthCare/Freedom

Medical Education
John Mooney
, CEO, M/C Communications LLC

A Whole New Ballgame
Mark Bouffard
, CEO, media imPRessions

Security and Sept. 11
Karen Kuller, Director, Marketing, SoftWatch Inc.

Stretching Dollars
Ed Mitzen, President/Owner, Palio Communications

On the West Coast
Patricia Malone, Principal, Stratagem Healthcare Communications LLC

On the Biotech Front
Dr. Richard Chipkin, CEO, Psychiatric Genomics Inc.

Regulatory completion
John M. Darcy, CEO, Aegis Analytical Corp.